Although other parameters like PSA or testosterone serum levels did not raise significant changes between groups, they found that the apoptosis index was significantly higher in isoflavone-treated patients, suggesting that isoflavones may halt the progression of prostate cancer via apoptosis induction in low- to moderate-grade tumors [256]. Here, KLK3 is linked to prostate carcinoma.